Hims & Hers Health, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Hims & Hers Health, Inc. reported a net loss of $86.3 million for the three months ended June 30, 2026, a significant increase from the net income of $42.5 million in the prior year period, driven by higher operating expenses and a lower gross margin.
NYSE
Hims & Hers Health, Inc. reported a 4% increase in total revenue for Q1 2026, reaching $608.1 million, but experienced a significant net loss of $92.1 million.
NYSE
Hims & Hers Health, Inc. reported a 49% increase in Q3 2025 revenue to $599.0 million, driven by personalized offerings, despite a 79% decrease in quarterly net income.
NYSE
Hims & Hers Health, Inc. reported robust financial results for Q2 2025, with significant increases in revenue and net income driven by strong subscriber growth and strategic expansion into new offerings.
NYSE
Hims & Hers Health, Inc. announces a significant increase in revenue and subscribers for the first quarter of 2025, driven by growth in online revenue and the introduction of new weight loss solutions.
NYSE
Hims & Hers Health, Inc. reports a profitable third quarter with significant revenue growth and the release of a valuation allowance on deferred tax assets.
NYSE
Hims & Hers Health, Inc. announced a 52% year-over-year increase in revenue for the second quarter of 2024, driven by growth in online sales and subscribers.
NYSE
Hims & Hers Health, Inc. announced a 46% increase in revenue for the first quarter of 2024, driven by growth in online sales and subscribers.